Literature DB >> 26123489

Analysis of YFP(J16)-R6/2 reporter mice and postmortem brains reveals early pathology and increased vulnerability of callosal axons in Huntington's disease.

Rodolfo G Gatto1, Yaping Chu2, Allen Q Ye3, Steven D Price1, Ehsan Tavassoli1, Andrea Buenaventura1, Scott T Brady1, Richard L Magin3, Jeffrey H Kordower2, Gerardo A Morfini4.   

Abstract

Cumulative evidence indicates that the onset and severity of Huntington's disease (HD) symptoms correlate with connectivity deficits involving specific neuronal populations within cortical and basal ganglia circuits. Brain imaging studies and pathological reports further associated these deficits with alterations in cerebral white matter structure and axonal pathology. However, whether axonopathy represents an early pathogenic event or an epiphenomenon in HD remains unknown, nor is clear the identity of specific neuronal populations affected. To directly evaluate early axonal abnormalities in the context of HD in vivo, we bred transgenic YFP(J16) with R6/2 mice, a widely used HD model. Diffusion tensor imaging and fluorescence microscopy studies revealed a marked degeneration of callosal axons long before the onset of motor symptoms. Accordingly, a significant fraction of YFP-positive cortical neurons in YFP(J16) mice cortex were identified as callosal projection neurons. Callosal axon pathology progressively worsened with age and was influenced by polyglutamine tract length in mutant huntingtin (mhtt). Degenerating axons were dissociated from microscopically visible mhtt aggregates and did not result from loss of cortical neurons. Interestingly, other axonal populations were mildly or not affected, suggesting differential vulnerability to mhtt toxicity. Validating these results, increased vulnerability of callosal axons was documented in the brains of HD patients. Observations here provide a structural basis for the alterations in cerebral white matter structure widely reported in HD patients. Collectively, our data demonstrate a dying-back pattern of degeneration for cortical projection neurons affected in HD, suggesting that axons represent an early and potentially critical target for mhtt toxicity.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26123489      PMCID: PMC4550824          DOI: 10.1093/hmg/ddv248

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  62 in total

1.  Mutant huntingtin downregulates myelin regulatory factor-mediated myelin gene expression and affects mature oligodendrocytes.

Authors:  Brenda Huang; WenJie Wei; Guohao Wang; Marta A Gaertig; Yue Feng; Wei Wang; Xiao-Jiang Li; Shihua Li
Journal:  Neuron       Date:  2015-03-18       Impact factor: 17.173

Review 2.  Choosing an animal model for the study of Huntington's disease.

Authors:  Mahmoud A Pouladi; A Jennifer Morton; Michael R Hayden
Journal:  Nat Rev Neurosci       Date:  2013-10       Impact factor: 34.870

3.  White matter connectivity reflects clinical and cognitive status in Huntington's disease.

Authors:  Govinda R Poudel; Julie C Stout; Juan F Domínguez D; Louisa Salmon; Andrew Churchyard; Phyllis Chua; Nellie Georgiou-Karistianis; Gary F Egan
Journal:  Neurobiol Dis       Date:  2014-01-28       Impact factor: 5.996

4.  A recoverable state of axon injury persists for hours after spinal cord contusion in vivo.

Authors:  Philip R Williams; Bogdan-Nicolae Marincu; Catherine D Sorbara; Christoph F Mahler; Adrian-Minh Schumacher; Oliver Griesbeck; Martin Kerschensteiner; Thomas Misgeld
Journal:  Nat Commun       Date:  2014-12-16       Impact factor: 14.919

5.  Late onset distal axonal swelling in YFP-H transgenic mice.

Authors:  Katherine E Bridge; Nicola Berg; Robert Adalbert; Elisabetta Babetto; Tatyana Dias; Maria-Grazia Spillantini; Richard R Ribchester; Michael P Coleman
Journal:  Neurobiol Aging       Date:  2007-07-19       Impact factor: 4.673

6.  In vivo evidence for the selective subcortical degeneration in Huntington's disease.

Authors:  Gwenaëlle Douaud; Timothy E Behrens; Cyril Poupon; Yann Cointepas; Saâd Jbabdi; Véronique Gaura; Narly Golestani; Pierre Krystkowiak; Christophe Verny; Philippe Damier; Anne-Catherine Bachoud-Lévi; Philippe Hantraye; Philippe Remy
Journal:  Neuroimage       Date:  2009-03-28       Impact factor: 6.556

7.  Age-related axonal swellings precede other neuropathological hallmarks in a knock-in mouse model of Huntington's disease.

Authors:  Martina Marangoni; Robert Adalbert; Lucie Janeckova; Jane Patrick; Jaskaren Kohli; Michael P Coleman; Laura Conforti
Journal:  Neurobiol Aging       Date:  2014-05-09       Impact factor: 4.673

8.  Systematic analysis of fly models with multiple drivers reveals different effects of ataxin-1 and huntingtin in neuron subtype-specific expression.

Authors:  Risa Shiraishi; Takuya Tamura; Masaki Sone; Hitoshi Okazawa
Journal:  PLoS One       Date:  2014-12-31       Impact factor: 3.240

9.  Early retinal function deficit without prominent morphological changes in the R6/2 mouse model of Huntington's disease.

Authors:  Symantas Ragauskas; Henri Leinonen; Jooseppi Puranen; Seppo Rönkkö; Soile Nymark; Kestutis Gurevicius; Arto Lipponen; Outi Kontkanen; Jukka Puoliväli; Heikki Tanila; Giedrius Kalesnykas
Journal:  PLoS One       Date:  2014-12-03       Impact factor: 3.240

10.  Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin.

Authors:  Gerardo A Morfini; Yi-Mei You; Sarah L Pollema; Agnieszka Kaminska; Katherine Liu; Katsuji Yoshioka; Benny Björkblom; Eleanor T Coffey; Carolina Bagnato; David Han; Chun-Fang Huang; Gary Banker; Gustavo Pigino; Scott T Brady
Journal:  Nat Neurosci       Date:  2009-06-14       Impact factor: 24.884

View more
  19 in total

1.  Detection of axonal degeneration in a mouse model of Huntington's disease: comparison between diffusion tensor imaging and anomalous diffusion metrics.

Authors:  Rodolfo G Gatto; Allen Q Ye; Luis Colon-Perez; Thomas H Mareci; Anna Lysakowski; Steven D Price; Scott T Brady; Muge Karaman; Gerardo Morfini; Richard L Magin
Journal:  MAGMA       Date:  2019-02-15       Impact factor: 2.310

2.  Early Downregulation of p75NTR by Genetic and Pharmacological Approaches Delays the Onset of Motor Deficits and Striatal Dysfunction in Huntington's Disease Mice.

Authors:  Nuria Suelves; Andrés Miguez; Saray López-Benito; Gerardo García-Díaz Barriga; Albert Giralt; Elena Alvarez-Periel; Juan Carlos Arévalo; Jordi Alberch; Silvia Ginés; Verónica Brito
Journal:  Mol Neurobiol       Date:  2018-05-27       Impact factor: 5.590

Review 3.  The Leukocentric Theory of Neurological Disorder: A Manifesto.

Authors:  Robert Fern
Journal:  Neurochem Res       Date:  2017-04-25       Impact factor: 3.996

4.  EGF Treatment Improves Motor Behavior and Cortical GABAergic Function in the R6/2 Mouse Model of Huntington's Disease.

Authors:  Felecia M Marottoli; Mercedes Priego; Eden Flores-Barrera; Rohan Pisharody; Steve Zaldua; Kelly D Fan; Giri K Ekkurthi; Scott T Brady; Gerardo A Morfini; Kuei Y Tseng; Leon M Tai
Journal:  Mol Neurobiol       Date:  2019-05-19       Impact factor: 5.590

Review 5.  Molecular insights into cortico-striatal miscommunications in Huntington's disease.

Authors:  Matthew B Veldman; X William Yang
Journal:  Curr Opin Neurobiol       Date:  2017-11-07       Impact factor: 6.627

Review 6.  Regulation of motor proteins, axonal transport deficits and adult-onset neurodegenerative diseases.

Authors:  Scott T Brady; Gerardo A Morfini
Journal:  Neurobiol Dis       Date:  2017-04-11       Impact factor: 5.996

7.  Early pridopidine treatment improves behavioral and transcriptional deficits in YAC128 Huntington disease mice.

Authors:  Marta Garcia-Miralles; Michal Geva; Jing Ying Tan; Nur Amirah Binte Mohammad Yusof; Yoonjeong Cha; Rebecca Kusko; Liang Juin Tan; Xiaohong Xu; Iris Grossman; Aric Orbach; Michael R Hayden; Mahmoud A Pouladi
Journal:  JCI Insight       Date:  2017-12-07

8.  Neurite orientation dispersion and density imaging can detect presymptomatic axonal degeneration in the spinal cord of ALS mice.

Authors:  R G Gatto; S M Mustafi; M Y Amin; T H Mareci; Yu-Chien Wu; R L Magin
Journal:  Funct Neurol       Date:  2018 Jul/Sept

9.  Longitudinal in vivo MRI in a Huntington's disease mouse model: Global atrophy in the absence of white matter microstructural damage.

Authors:  Jessica J Steventon; Rebecca C Trueman; Da Ma; Emma Yhnell; Zubeyde Bayram-Weston; Marc Modat; Jorge Cardoso; Sebastian Ourselin; Mark Lythgoe; Andrew Stewart; Anne E Rosser; Derek K Jones
Journal:  Sci Rep       Date:  2016-09-01       Impact factor: 4.379

10.  Impaired Levels of Gangliosides in the Corpus Callosum of Huntington Disease Animal Models.

Authors:  Alba Di Pardo; Enrico Amico; Vittorio Maglione
Journal:  Front Neurosci       Date:  2016-10-06       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.